Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
450
Trial Sponsor
Clinical Trial Start Date
March 12, 2018
0Primary Completion Date
October 23, 2018
0Study Completion Date
March 21, 2020
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Other0
Drug0
Intervention Name
Sterile Normal Saline (0.9% NaCl)0
ARO-AAT Injection0
Interventional Trial Phase
Phase 10
Official Name
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Effect of ARO-AAT on Serum Alpha-1 Antitrypsin Levels in Normal Adult Volunteers0
Last Updated
August 18, 2020
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Participant0
Investigator0
Study summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single- and multiple-ascending doses of ARO-AAT in healthy adult volunteers.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
